Clinical Trial Update: Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial Neoplasia [Phase 1]

View source ↗

Summary

A Phase 1 trial investigating photodynamic therapy with lutetium texaphyrin for cervical intraepithelial neoplasia and cervical cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Intraepithelial Neoplasia

Drugs mentioned

• Lutetium texaphyrin (lutetium texaphyrin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cervical Cancer, Cervical Intraepithelial Neoplasia Grade 2 | Phase 1 | Status: TERMINATED